RE:RE:RE:RE:Approval for Phase 2b/3 294ever, I disagree. It will take a few months to enroll patients, but not all need to be enrolled to start a trail, ie: they are still enrolling after first patient dosed. This is a "continuous process". Below is the excerpt from the article, if we are taking this article "literally", then we should expect data in late Octorber / November 2020, 4th quarter of this year. Hmmm.. Just in time of the second wave??
JMO
-BehStreet
"The company anticipates it will take a few months to enroll all the patients. The treatment lasts two weeks, and another two weeks are needed for follow up, and then time for data collection, so within three to four months Algernon expects to have data about the drug's efficacy as a treatment for Covid-19."